Micron announces collaboration with leading biopharmaceutical company

ATLANTA, February 12, 2016 -Micron Biomedical, Inc. announces that it has entered into a research agreement with a leading European biopharmaceutical company to assess the suitability of its microneedle patch technology for delivery of the company’s nucleic acid platform technology.  The name of the company and the terms of the agreement are confidential.